SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $23.2M invested in Salarius Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

21% less capital invested

Capital invested by funds: $29.5M → $23.2M (-$6.29M)

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.05M
2
+$1.94M
3
+$711K
4
CWG
C WorldWide Group
Denmark
+$306K
5
SIM
Spark Investment Management
New York
+$223K

Top Sellers

1
-$1.73M
2
-$1.7M
3
-$876K
4
Millennium Management
Millennium Management
New York
-$422K
5
TCIM
TIAA CREF Investment Management
New York
-$181K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$46K
27
$45K
28
$44K
29
$41K
30
$33K
31
$29K
32
$29K
33
$18K
34
$13K
35
$11K
36
$8K
37
$3K
38
$2K
39
$2K
40
$2K
41
$1K
42
$1K
43
$198
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3